Yes. People with no symptoms can and do transmit SARS-CoV-2, but they are not equally infectious at every stage of the disease. The best evidence puts presymptomatic spread—transmission in the 1-3 days before symptoms appear—at roughly 40-60% of all transmission events, while truly asymptomatic carriers (who never develop symptoms) account for a smaller share, generally estimated at 15-30% of infections and an even lower fraction of onward spread. The mechanism is straightforward: peak viral shedding begins 1-2 days before symptom onset, so a person feels fine while exhaling the most virus.
The Mechanism: Why No Symptoms Does Not Mean No Virus
The virus does not wait for symptoms. SARS-CoV-2 binds ACE2 receptors in the upper airway, and replication ramps up over several days. Viral load in the nose and throat peaks around the day symptoms would begin—or one to two days earlier.
This creates a window where a person is shedding heavily but feeling normal. Coughing is not required for transmission. Normal breathing, talking, and singing emit respiratory particles in the 1-10 micrometer range, and these can carry infectious virus.
In plain terms: the loudest spreader is often the person who does not know they are sick.
Symptom onset reflects the immune response, not the start of infectiousness. By the time fever or cough appears, the immune system is already fighting—often after the peak shedding window has passed. This decoupling of "feeling sick" from "being infectious" is the core reason asymptomatic and presymptomatic spread exists.
Quantified Context: How Much Spread Comes From Silent Carriers
The clearest number comes from Singapore's contract-tracing data, analyzed in a 2020 study by Wei and colleagues: an estimated 44% of secondary cases were infected by someone in the presymptomatic stage. Other modeling has placed presymptomatic transmission between 40% and 60% of total events.
Truly asymptomatic infection is harder to pin down. Estimates from contact-tracing studies range from 15% to 30% of all infections never producing symptoms. But asymptomatic people shed less virus on average and are less likely to generate the forceful exhalations that drive transmission.
The distinction matters for public health:
| Category | Share of infections | Relative infectiousness | Peak shedding window |
|---|---|---|---|
| Presymptomatic | 30-40% | High | 1-2 days before symptoms |
| Truly asymptomatic | 15-30% | Low to moderate | Variable, often lower |
| Symptomatic | 40-55% | High | Day of onset through day 3 |
| Post-symptom (day 10+) | All | Very low | Non-viable virus common |
Per the WHO's 2020 transmission guidance, both presymptomatic and asymptomatic spread were confirmed as meaningful drivers of community transmission, with presymptomatic contact carrying the larger share.
The Timeline of Silent Transmission
Infectiousness follows a predictable curve relative to symptom onset—day zero being the first day of symptoms.
| Day (relative to symptom onset) | What is happening | Transmission risk |
|---|---|---|
| Day -3 to -2 | Viral replication begins in airway | Low |
| Day -2 to -1 | Shedding climbs sharply | Rising, presymptomatic |
| Day -1 to 0 | Peak viral load reached | Highest risk, often presymptomatic |
| Day 0 | Symptoms appear | High |
| Day 1-3 | Shedding declines in most people | Moderate |
| Day 5-7 | Rapid fall in viable virus | Low |
| Day 10+ | Live virus rarely recoverable | Minimal for most |
Per the CDC's isolation guidance, most people are no longer infectious 10 days after symptom onset (or after a positive test if asymptomatic), which aligns with the sharp drop in viable virus seen after day 7.
Why Some People Never Get Symptoms
Asymptomatic infection is not purely luck. Several factors shift the odds:
- Prior immunity from vaccination or earlier infection blunts the inflammatory response that produces fever and cough.
- Age matters: children and young adults clear the virus with fewer symptoms—one reason schools became quiet transmission hubs.
- Genetics of the immune system, particularly HLA type, influence how forcefully the body reacts.
- Viral dose at exposure shapes the initial replication burst.
- The variant matters; Omicron sublineages produced more asymptomatic cases than the original strain.
A counterintuitive detail: a person with no symptoms can have a viral load as high as a hospitalized patient. The difference is not how much virus they carry but how much they expel and how their immune system responds. High viral load does not equal high transmission without the behaviors—close contact, poor ventilation—that move particles between people.
Common Misconceptions, Corrected
Three errors recur in popular coverage. First, the idea that "asymptomatic means not contagious" is false. Presymptomatic people, in particular, transmit heavily.
Second, the idea that a negative rapid antigen test clears an asymptomatic person is overstated. Rapid tests detect virus best when viral loads are high and symptoms are present; in asymptomatic people they are less sensitive, missing perhaps 20-40% of infectious cases depending on timing and variant.
Third, the belief that asymptomatic spread means masks and ventilation do not matter is backwards. Because silent carriers cannot be identified by symptom screening, layered measures—ventilation, masking in crowded indoor spaces, testing after exposure—carry more weight, not less. Symptom-based screening alone misses the people most likely to spread undetected.
What to Actually Do
You cannot screen out silent carriers by looking at them. The practical actions are structural:
- Improve indoor air with ventilation and filtration—target at least 5 air changes per hour in shared rooms.
- Test after known exposure, ideally on day 3-5, rather than waiting for symptoms.
- Wear a well-fitting mask in crowded indoor settings during high-transmission periods.
- Isolate for 5 days after a positive test even without symptoms, per current CDC guidance, and mask for the following 5.
- Treat a positive test as real regardless of how you feel; asymptomatic does not mean non-infectious.
Limits of the Evidence
The precise split between asymptomatic and presymptomatic spread remains uncertain. Studies rely on contact tracing, which misses untraced contacts and depends on people reporting symptoms accurately. Many "asymptomatic" cases in early studies may have been presymptomatic people who developed symptoms after the study window closed.
Estimates also shift by variant and population immunity. Pre-Omicron data overstate severe outcomes; post-Omicron data reflect a more immune population. Treat any single percentage as a range, not a fixed law. The direction, however, is settled: silent carriers spread the virus, and presymptomatic transmission is a major driver.